LEADER 02245oam  2200397z- 450 
001 9911006814403321
005 20150519083720.0
010   $a0-8031-7061-0
010   $a1-5231-0596-8
035   $a(CKB)3810000000287741
035   $a(EXLCZ)993810000000287741
100   $a20210427c2014uuuu  -u-         -
101 0 $aeng
200 10$aBone graft substitutes and bone regenerative engineering /$f[edited by] Cato T. Laurencin, M.D., Ph. D., Tao Jiang, MBA
210   $cASTM International
311   $a0-8031-7060-2 
327   $aBone graft substitutes : past, present, and future -- Bone graft substitutes : classifications and orthopaedic applications -- Xenograft use in orthopaedic surgery -- Bone grafts based on demineralized bone matrix -- Clinical perspectives on the use of allogenic tissue substitutes -- Cell-based approaches for bone regeneration -- Review of state of the art : growth factor-based systems for use as bone -- Graft substitutes -- Bone morphogenetic proteins in human bone regeneration : successes and challenges -- Synthetic biomimetic porous polymer scaffolds for bone regeneration synthetic bone graft substitutes : basic information for successful -- Clinical use -- Bone graft substitutes : a regulatory perspectives -- Nanoscale technologies for bone grafting -- New bone grafting technologies using stem cells -- Strategies towards engineering vascularized bone graft substitutes regenerative engineering : fulfilling the tissue engineering promise to -- Bone regeneration.
517   $aBone Graft Substitutes and Bone Regenerative Engineering 
606   $aBone Regeneration
606   $aBone Substitutes
606   $aBone Transplantation$xmethods
606   $aBone Morphogenetic Proteins
606   $aGrowth Substances
615 12$aBone Regeneration.
615 12$aBone Substitutes.
615 12$aBone Transplantation$xmethods.
615 22$aBone Morphogenetic Proteins.
615 22$aGrowth Substances.
676   $a617.4/710592
702   $aLaurencin$b Cato T.
702   $aJiang$b Tao$f1978-
712 02$aASTM International,
906   $aBOOK
912   $a9911006814403321
996   $aBone graft substitutes and bone regenerative engineering$94389101
997   $aUNINA